[4-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid
|
- $323 - $874
- Product name: [4-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid
- CAS: 675856-56-1
- MF: C14H15NO2S
- MW: 261.34
- EINECS:
- MDL Number:MFCD06253059
- Synonyms:ASINEX-REAG BAS 10159489;5-Thiazoleacetic acid, 4-(3,4-dimethylphenyl)-2-methyl-;2-(4-(3,4-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid;[4-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 1.00g
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM377254
- Product description2-[4-(3,4-dimethylphenyl)-2-methyl-1,3-thiazol-5-yl]acetic acid 95%+
- Packaging1g
- Price$323
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11074417
- Product description2-(4-(3,4-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid 97%
- Packaging5g
- Price$874
- Updated2026-05-26
- Buy
- ManufacturerMatrix Scientific
- Product number019304
- Product description[4-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number019304
- Product description[4-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid
- Packaging1.00g
- Price$378
- Updated2026-05-18
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM377254 | 2-[4-(3,4-dimethylphenyl)-2-methyl-1,3-thiazol-5-yl]acetic acid 95%+ | 1g | $323 | 2026-05-26 | Buy |
| Crysdot | CD11074417 | 2-(4-(3,4-Dimethylphenyl)-2-methylthiazol-5-yl)acetic acid 97% | 5g | $874 | 2026-05-26 | Buy |
| Matrix Scientific | 019304 | [4-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid | 1g | $378 | 2021-12-16 | Buy |
| Matrix Scientific | 019304 | [4-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid | 1.00g | $378 | 2026-05-18 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




